Related Experiment Videos
Elevated TFPI levels in female hyperhomocysteinemic patients
Elmar Thyzel1, Sabine Siegling, Christian Götting
1Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
Clinical Biochemistry
|August 6, 2005
Summary
Elevated homocysteine levels increase tissue factor pathway inhibitor (TFPI) in patients. This effect is more pronounced in females, indicating a gender-dependent link between hyperhomocysteinemia and TFPI.
Area of Science:
- Biochemistry
- Cardiovascular Science
- Hematology
Background:
- Hyperhomocysteinemia is a known risk factor for cardiovascular diseases.
- Tissue factor pathway inhibitor (TFPI) plays a crucial role in regulating blood coagulation via the extrinsic pathway.
Purpose of the Study:
- To investigate the in vivo impact of elevated homocysteine concentrations on TFPI levels.
- To determine if hyperhomocysteinemia influences TFPI in a gender-specific manner.
Main Methods:
- Total TFPI levels were measured in 82 patients diagnosed with hyperhomocysteinemia.
- Patient TFPI levels were compared to those of healthy blood donors.
Main Results:
- Patients with hyperhomocysteinemia exhibited significantly elevated TFPI levels compared to controls.
- The elevation in TFPI was more pronounced in female patients than in male patients.
Conclusions:
- A significant gender-dependent elevation of TFPI was observed in patients with hyperhomocysteinemia.
- These findings highlight a potential sex-specific interaction between homocysteine metabolism and coagulation regulation.